ABL Bio Inc
KOSDAQ:298380
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
18 450
41 350
|
Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ABL Bio Inc stock under the Base Case scenario is 4 390.06 KRW. Compared to the current market price of 33 050 KRW, ABL Bio Inc is Overvalued by 87%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
ABL Bio Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for ABL Bio Inc cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
ABL Bio Inc
Balance Sheet Decomposition
ABL Bio Inc
Current Assets | 36.1B |
Cash & Short-Term Investments | 33.7B |
Receivables | 434.8m |
Other Current Assets | 2B |
Non-Current Assets | 84.6B |
Long-Term Investments | 1.7B |
PP&E | 79.9B |
Intangibles | 2.5B |
Other Non-Current Assets | 523.3m |
Current Liabilities | 23.4B |
Accrued Liabilities | 309.3m |
Other Current Liabilities | 23.1B |
Non-Current Liabilities | 44.2B |
Long-Term Debt | 43B |
Other Non-Current Liabilities | 1.2B |
Earnings Waterfall
ABL Bio Inc
Revenue
|
24.4B
KRW
|
Operating Expenses
|
-60.1B
KRW
|
Operating Income
|
-35.8B
KRW
|
Other Expenses
|
-141.5m
KRW
|
Net Income
|
-35.9B
KRW
|
Free Cash Flow Analysis
ABL Bio Inc
KRW | |
Free Cash Flow | KRW |
Profitability Score
Profitability Due Diligence
ABL Bio Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Score
ABL Bio Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
ABL Bio Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
ABL Bio Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
ABL Bio Inc
According to Wall Street analysts, the average 1-year price target for ABL Bio Inc is 48 280 KRW with a low forecast of 37 370 KRW and a high forecast of 63 000 KRW.
Dividends
Current shareholder yield for ABL Bio Inc is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
ABL Bio, Inc. engages in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-12-19. The major products include anti-angiogenesis antibodies anti-tumor targeting antibodies, T cell engager bispecific antibodies (TCEs), dual immune cell targeting bispecific antibodies (DICs), novel immune cell targeting antibodies (NICs), brain disease dual antibodies, antibody-drug conjugates (ADCs) , among others.
Contact
IPO
Employees
Officers
The intrinsic value of one ABL Bio Inc stock under the Base Case scenario is 4 390.06 KRW.
Compared to the current market price of 33 050 KRW, ABL Bio Inc is Overvalued by 87%.